Dianthus Therapeutics stock forecast
Dianthus Therapeutics (87E) Stock Forecast & Price Target
87E Analyst Ratings
87E Stock 12 Month Forecast
Average Price Target
€128.73▲(63.99% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Adam Walsh | Roth MKM | €102.52 | buy | 30.60%Upside | Reiterated | 11/16/26 | ||
| Alex Thompson CFA | Stifel Nicolaus | €120.66 | buy | 53.71%Upside | Reiterated | 11/13/26 | ||
| Swayampakula Ramakanth | H.C. Wainwright | €143.35 | buy | 82.61%Upside | Reiterated | 11/06/26 | ||
| Sadia Rahman | Wells Fargo | €122.48 | buy | 56.02%Upside | Reiterated | 11/05/26 | ||
| Laura Chico | Wedbush | €110.68 | buy | 41.00%Upside | Reiterated | 11/05/26 | ||
| Brian Cheng | J.P. Morgan | €122.48 | buy | 56.02%Upside | Reiterated | 11/05/26 | ||
| Guggenheim | €181.45 | buy | 131.15%Upside | Reiterated | 11/05/26 | |||
| Rami Katkhuda | LifeSci Capital | €113.41 | buy | 44.47%Upside | Reiterated | 09/29/26 | ||
| Myles Minter | William Blair | ― | buy | ― | Reiterated | 09/18/26 | ||
| Samantha Semenkow | Citi | €141.53 | buy | 80.29%Upside | Initiated | 09/04/26 | ||
| Gavin Clark-Gartner | Evercore ISI | €121.57 | buy | 54.87%Upside | Reiterated | 08/10/26 | ||
| Danielle Brill | Truist Financial | €99.80→€116.13 | buy | 47.93%Upside | Reiterated | 08/06/26 | ||
| Yaron Werber | TD Cowen | €136.09 | buy | 73.36%Upside | Assigned | 08/05/26 | ||
| William Maughan | Clear Street | €117.94 | buy | 50.25%Upside | Reiterated | 08/05/26 | ||
| Maury Raycroft | Jefferies | €119.76 | buy | 52.56%Upside | Reiterated | 06/15/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Adam WalshRoth MKM | BuyReiterated€102.52 | 11/16/26 | 30.60%Upside | ||
| Alex Thompson CFAStifel Nicolaus | BuyReiterated€120.66 | 11/13/26 | 53.71%Upside | ||
| Swayampakula RamakanthH.C. Wainwright | BuyReiterated€143.35 | 11/06/26 | 82.61%Upside | ||
| Sadia RahmanWells Fargo | BuyReiterated€122.48 | 11/05/26 | 56.02%Upside | ||
| Laura ChicoWedbush | BuyReiterated€110.68 | 11/05/26 | 41.00%Upside | ||
| Brian ChengJ.P. Morgan | BuyReiterated€122.48 | 11/05/26 | 56.02%Upside | ||
| BuyReiterated€181.45 | 11/05/26 | 131.15%Upside | |||
| Rami KatkhudaLifeSci Capital | BuyReiterated€113.41 | 09/29/26 | 44.47%Upside | ||
| Myles MinterWilliam Blair | BuyReiterated | 09/18/26 | ― | ||
| Samantha SemenkowCiti | BuyInitiated€141.53 | 09/04/26 | 80.29%Upside | ||
| Gavin Clark-GartnerEvercore ISI | BuyReiterated€121.57 | 08/10/26 | 54.87%Upside | ||
| Danielle BrillTruist Financial | BuyReiterated€99.80→€116.13 | 08/06/26 | 47.93%Upside | ||
| Yaron WerberTD Cowen | BuyAssigned€136.09 | 08/05/26 | 73.36%Upside | ||
| William MaughanClear Street | BuyReiterated€117.94 | 08/05/26 | 50.25%Upside | ||
| Maury RaycroftJefferies | BuyReiterated€119.76 | 06/15/26 | 52.56%Upside |
Best Analysts Covering Dianthus Therapeutics
Copying Gavin Clark-Gartner's trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +48.15% per trade.
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +111.05% per trade.
Copying Rami Katkhuda's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +184.29% per trade.
87E Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 1 | 4 | 8 |
| Buy | 16 | 19 | 17 | 17 | 9 |
| Hold | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 24 | 26 | 18 | 21 | 17 |
In the current month, 87E has received 17 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 87E average Analyst price target in the past 3 months is 128.73.
87E Financial Forecast
87E Earnings Forecast
Next quarter’s earnings estimate for 87E is -EUR 0.87 with a range of -EUR 0.98 to -EUR 0.76. The previous quarter’s EPS was -EUR 0.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
87E Sales Forecast
Next quarter’s sales forecast for 87E is EUR 404.96K with a range of EUR 0 to EUR 1.09M. The previous quarter’s sales results were EUR 1.09M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

